Abstract:Background MicroRNAs (miRNAs) are short, non-coding RNAs (~22 nt) that play important roles in the pathogenesis of human diseases by negatively regulating gene expression. Although miR-196a has been implicated in several other cancers, its role in non-small cell lung cancer (NSCLC) is unknown. The aim of the present study was to examine the expression pattern of miR-196a in NSCLC and its clinical significance, as well as its biological role in tumor progression. Methods Expression of miR-196a was analyzed in 34 NSCLC tissues and five NSCLC cell lines by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The effect of DNA methylation on miR-196a expression was investigated by 5-aza-2-deoxy-cytidine treatment and bisulfite sequencing. The effect of miR-196a on proliferation was evaluated by MTT and colony formation assays, and cell migration and invasion were evaluated by transwell assays. Analysis of target protein expression was determined by western blotting. Luciferase reporter plasmids were constructed to confirm the action of miR-196a on downstream target genes, including HOXA5 . Differences between the results were tested for significance using Student’s t-test (two-tailed). Results miR-196a was highly expressed both in NSCLC samples and cell lines compared with their corresponding normal counterparts, and the expression of miR-196a may be affected by DNA demethylation. Higher expression of miR-196a in NSCLC tissues was associated with a higher clinical stage, and also correlated with NSCLC lymph-node metastasis. In vitro functional assays demonstrated that modulation of miR-196a expression affected NSCLC cell proliferation, migration and invasion. Our analysis showed that miR-196a suppressed the expression of HOXA5 both at the mRNA and protein levels, and luciferase assays confirmed that miR-196a directly bound to the 3’untranslated region of HOXA5. Knockdown of HOXA5 expression in A549 cells using RNAi was shown to promote NSCLC cell proliferation, migration and invasion. Finally, we observed an inverse correlation between HOXA5 and miR-196a expression in NSCLC tissues. Conclusions Our findings indicate that miR-196a is significantly up-regulated in NSCLC tissues, and regulates NSCLC cell proliferation, migration and invasion, partially via the down-regulation of HOXA5. Thus, miR-196a may represent a potential therapeutic target for NSCLC intervention.

Microrna-181B Suppresses the Metastasis of Lung Cancer Cells by Targeting Sex Determining Region Y-related High Mobility Group-Box 6 (Sox6)

MicroRNA-206 Inhibits the Viability and Migration of Human Lung Adenocarcinoma Cells Partly by Targeting MET.

Microrna-187 Inhibits Pten Expression And Promotes Cell Proliferation In Non-Small-Cell Lung Cancer

miRNA‐215‐5p suppresses the aggressiveness of breast cancer cells by targeting Sox9

MiR-124 Inhibits Cell Proliferation, Migration and Invasion by Directly Targeting SOX9 in Lung Adenocarcinoma.

MicroRNA-218 Functions As a Tumor Suppressor in Lung Cancer by Targeting IL-6/STAT3 and Negatively Correlates with Poor Prognosis

Microrna-206 Is Associated With Invasion And Metastasis Of Lung Cancer

Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation

Mir-497-5p Inhibits Tumor Cell Growth and Invasion by Targeting SOX5 in Non-Small-cell Lung Cancer

MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2

Mir-24-3p Promotes Cell Migration and Proliferation in Lung Cancer by Targeting SOX7.

Exosomal miR-3180-3p inhibits proliferation and metastasis of non-small cell lung cancer by downregulating FOXP4

miR-155-5p Promotes Invasion and Migration of MCF-7 Breast Cancer Cell by Down-regulating SOX1

MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer.

MicroRNA-196a Promotes Non-Small Cell Lung Cancer Cell Proliferation and Invasion Through Targeting HOXA5

MicroRNA Mir-590-5p Inhibits Breast Cancer Cell Stemness and Metastasis by Targeting SOX2.

Microrna-145 Suppresses Lung Adenocarcinoma-Initiating Cell Proliferation by Targeting OCT4.

miR-183-5p regulates ECM and EMT to promote non-small cell lung cancer progression by targeting LOXL4

MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer

Exosomes-Derived MiR-302b Suppresses Lung Cancer Cell Proliferation and Migration Via TGFβRII Inhibition

Up-regulation of miR-1825 p predicts poor prognosis in patients with lung cancer and associates with tumor cell growth and migration